Effects of Early Postoperative Showering After Coronary Artery Bypass Grafting Using Bilateral Internal Thoracic Artery
Launched by SEJONG GENERAL HOSPITAL · Jan 23, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of taking a shower soon after having heart surgery called coronary artery bypass grafting, which uses two major blood vessels from the chest. The researchers want to see if showering early after surgery can help with healing and reduce the chances of developing infections in the wounds. Currently, the trial is looking for participants who are at least 18 years old and have recently had this specific type of heart surgery, provided they have had all their drainage tubes and heart pacing wires removed.
If you or someone you know is considering joining this trial, you would expect to follow some guidelines to ensure safety, such as not having any serious complications after surgery or open wounds. The trial is open to all genders and is currently recruiting participants, so it’s a great opportunity to contribute to important research that could benefit future patients undergoing similar surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18
- • Patients who underwent coronary bypass grafting with bilateral internal thoracic artery through median sternotomy
- • Patients whose all drains or pacing wires are removed
- Exclusion Criteria:
- • Concomitant operation
- • Redo-surgery
- • prolonged intensive care unit stay (more than 4 days) due to serious complications after surgery
- • open wounds
- • active infection
- • prolonged drains
About Sejong General Hospital
Sejong General Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a focus on evidence-based practices, the hospital collaborates with a diverse team of healthcare professionals and researchers to conduct comprehensive clinical studies across various therapeutic areas. By fostering an environment of collaboration and integrity, Sejong General Hospital aims to contribute significantly to the development of new treatments and enhance the overall quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bucheon, Gyeonggi Do, Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported